Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Asthma Reliever (Rescue) Medications Market Growth 2022-2028

  • LP 4945682
  • 103 Pages
  • April 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Asthma Reliever (Rescue) Medications will have significant change from previous year. According to our (LP Information) latest study, the global Asthma Reliever (Rescue) Medications market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Asthma Reliever (Rescue) Medications market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Asthma Reliever (Rescue) Medications market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Asthma Reliever (Rescue) Medications market, reaching US$ million by the year 2028. As for the Europe Asthma Reliever (Rescue) Medications landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Asthma Reliever (Rescue) Medications players cover Dulera, QVAR, Glaxosmithkline plc, and MAP Pharmaceuticals,Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Asthma Reliever (Rescue) Medications market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Quick-Relief Medications

Long-Term Control Medications

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Children

Adolescent

Adult

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Dulera

QVAR

Glaxosmithkline plc

MAP Pharmaceuticals,Inc

Merck & Co. Inc

AstraZeneca plc

Roche Holdings Ltd

Genentech Inc

Sepracor, Inc

Schering-Plough Corp

Sanofi-Aventis

Theravance Inc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Asthma Reliever (Rescue) Medications Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Asthma Reliever (Rescue) Medications by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Asthma Reliever (Rescue) Medications by Country/Region, 2017, 2022 & 2028

2.2 Asthma Reliever (Rescue) Medications Segment by Type

2.2.1 Quick-Relief Medications

2.2.2 Long-Term Control Medications

2.3 Asthma Reliever (Rescue) Medications Sales by Type

2.3.1 Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2022)

2.3.2 Global Asthma Reliever (Rescue) Medications Revenue and Market Share by Type (2017-2022)

2.3.3 Global Asthma Reliever (Rescue) Medications Sale Price by Type (2017-2022)

2.4 Asthma Reliever (Rescue) Medications Segment by Application

2.4.1 Children

2.4.2 Adolescent

2.4.3 Adult

2.5 Asthma Reliever (Rescue) Medications Sales by Application

2.5.1 Global Asthma Reliever (Rescue) Medications Sale Market Share by Application (2017-2022)

2.5.2 Global Asthma Reliever (Rescue) Medications Revenue and Market Share by Application (2017-2022)

2.5.3 Global Asthma Reliever (Rescue) Medications Sale Price by Application (2017-2022)

3 Global Asthma Reliever (Rescue) Medications by Company

3.1 Global Asthma Reliever (Rescue) Medications Breakdown Data by Company

3.1.1 Global Asthma Reliever (Rescue) Medications Annual Sales by Company (2020-2022)

3.1.2 Global Asthma Reliever (Rescue) Medications Sales Market Share by Company (2020-2022)

3.2 Global Asthma Reliever (Rescue) Medications Annual Revenue by Company (2020-2022)

3.2.1 Global Asthma Reliever (Rescue) Medications Revenue by Company (2020-2022)

3.2.2 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Company (2020-2022)

3.3 Global Asthma Reliever (Rescue) Medications Sale Price by Company

3.4 Key Manufacturers Asthma Reliever (Rescue) Medications Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Asthma Reliever (Rescue) Medications Product Location Distribution

3.4.2 Players Asthma Reliever (Rescue) Medications Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Asthma Reliever (Rescue) Medications by Geographic Region

4.1 World Historic Asthma Reliever (Rescue) Medications Market Size by Geographic Region (2017-2022)

4.1.1 Global Asthma Reliever (Rescue) Medications Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Asthma Reliever (Rescue) Medications Annual Revenue by Geographic Region

4.2 World Historic Asthma Reliever (Rescue) Medications Market Size by Country/Region (2017-2022)

4.2.1 Global Asthma Reliever (Rescue) Medications Annual Sales by Country/Region (2017-2022)

4.2.2 Global Asthma Reliever (Rescue) Medications Annual Revenue by Country/Region

4.3 Americas Asthma Reliever (Rescue) Medications Sales Growth

4.4 APAC Asthma Reliever (Rescue) Medications Sales Growth

4.5 Europe Asthma Reliever (Rescue) Medications Sales Growth

4.6 Middle East & Africa Asthma Reliever (Rescue) Medications Sales Growth

5 Americas

5.1 Americas Asthma Reliever (Rescue) Medications Sales by Country

5.1.1 Americas Asthma Reliever (Rescue) Medications Sales by Country (2017-2022)

5.1.2 Americas Asthma Reliever (Rescue) Medications Revenue by Country (2017-2022)

5.2 Americas Asthma Reliever (Rescue) Medications Sales by Type

5.3 Americas Asthma Reliever (Rescue) Medications Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Asthma Reliever (Rescue) Medications Sales by Region

6.1.1 APAC Asthma Reliever (Rescue) Medications Sales by Region (2017-2022)

6.1.2 APAC Asthma Reliever (Rescue) Medications Revenue by Region (2017-2022)

6.2 APAC Asthma Reliever (Rescue) Medications Sales by Type

6.3 APAC Asthma Reliever (Rescue) Medications Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Asthma Reliever (Rescue) Medications by Country

7.1.1 Europe Asthma Reliever (Rescue) Medications Sales by Country (2017-2022)

7.1.2 Europe Asthma Reliever (Rescue) Medications Revenue by Country (2017-2022)

7.2 Europe Asthma Reliever (Rescue) Medications Sales by Type

7.3 Europe Asthma Reliever (Rescue) Medications Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Asthma Reliever (Rescue) Medications by Country

8.1.1 Middle East & Africa Asthma Reliever (Rescue) Medications Sales by Country (2017-2022)

8.1.2 Middle East & Africa Asthma Reliever (Rescue) Medications Revenue by Country (2017-2022)

8.2 Middle East & Africa Asthma Reliever (Rescue) Medications Sales by Type

8.3 Middle East & Africa Asthma Reliever (Rescue) Medications Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Asthma Reliever (Rescue) Medications

10.3 Manufacturing Process Analysis of Asthma Reliever (Rescue) Medications

10.4 Industry Chain Structure of Asthma Reliever (Rescue) Medications

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Asthma Reliever (Rescue) Medications Distributors

11.3 Asthma Reliever (Rescue) Medications Customer

12 World Forecast Review for Asthma Reliever (Rescue) Medications by Geographic Region

12.1 Global Asthma Reliever (Rescue) Medications Market Size Forecast by Region

12.1.1 Global Asthma Reliever (Rescue) Medications Forecast by Region (2023-2028)

12.1.2 Global Asthma Reliever (Rescue) Medications Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Asthma Reliever (Rescue) Medications Forecast by Type

12.7 Global Asthma Reliever (Rescue) Medications Forecast by Application

13 Key Players Analysis

13.1 Dulera

13.1.1 Dulera Company Information

13.1.2 Dulera Asthma Reliever (Rescue) Medications Product Offered

13.1.3 Dulera Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Dulera Main Business Overview

13.1.5 Dulera Latest Developments

13.2 QVAR

13.2.1 QVAR Company Information

13.2.2 QVAR Asthma Reliever (Rescue) Medications Product Offered

13.2.3 QVAR Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 QVAR Main Business Overview

13.2.5 QVAR Latest Developments

13.3 Glaxosmithkline plc

13.3.1 Glaxosmithkline plc Company Information

13.3.2 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Offered

13.3.3 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Glaxosmithkline plc Main Business Overview

13.3.5 Glaxosmithkline plc Latest Developments

13.4 MAP Pharmaceuticals,Inc

13.4.1 MAP Pharmaceuticals,Inc Company Information

13.4.2 MAP Pharmaceuticals,Inc Asthma Reliever (Rescue) Medications Product Offered

13.4.3 MAP Pharmaceuticals,Inc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 MAP Pharmaceuticals,Inc Main Business Overview

13.4.5 MAP Pharmaceuticals,Inc Latest Developments

13.5 Merck & Co. Inc

13.5.1 Merck & Co. Inc Company Information

13.5.2 Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Offered

13.5.3 Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Merck & Co. Inc Main Business Overview

13.5.5 Merck & Co. Inc Latest Developments

13.6 AstraZeneca plc

13.6.1 AstraZeneca plc Company Information

13.6.2 AstraZeneca plc Asthma Reliever (Rescue) Medications Product Offered

13.6.3 AstraZeneca plc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 AstraZeneca plc Main Business Overview

13.6.5 AstraZeneca plc Latest Developments

13.7 Roche Holdings Ltd

13.7.1 Roche Holdings Ltd Company Information

13.7.2 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Offered

13.7.3 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Roche Holdings Ltd Main Business Overview

13.7.5 Roche Holdings Ltd Latest Developments

13.8 Genentech Inc

13.8.1 Genentech Inc Company Information

13.8.2 Genentech Inc Asthma Reliever (Rescue) Medications Product Offered

13.8.3 Genentech Inc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Genentech Inc Main Business Overview

13.8.5 Genentech Inc Latest Developments

13.9 Sepracor, Inc

13.9.1 Sepracor, Inc Company Information

13.9.2 Sepracor, Inc Asthma Reliever (Rescue) Medications Product Offered

13.9.3 Sepracor, Inc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sepracor, Inc Main Business Overview

13.9.5 Sepracor, Inc Latest Developments

13.10 Schering-Plough Corp

13.10.1 Schering-Plough Corp Company Information

13.10.2 Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Offered

13.10.3 Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Schering-Plough Corp Main Business Overview

13.10.5 Schering-Plough Corp Latest Developments

13.11 Sanofi-Aventis

13.11.1 Sanofi-Aventis Company Information

13.11.2 Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Offered

13.11.3 Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Sanofi-Aventis Main Business Overview

13.11.5 Sanofi-Aventis Latest Developments

13.12 Theravance Inc

13.12.1 Theravance Inc Company Information

13.12.2 Theravance Inc Asthma Reliever (Rescue) Medications Product Offered

13.12.3 Theravance Inc Asthma Reliever (Rescue) Medications Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Theravance Inc Main Business Overview

13.12.5 Theravance Inc Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Asthma Reliever (Rescue) Medications Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Asthma Reliever (Rescue) Medications Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Quick-Relief Medications

Table 4. Major Players of Long-Term Control Medications

Table 5. Global Asthma Reliever (Rescue) Medications Sales by Type (2017-2022) & (K Units)

Table 6. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2022)

Table 7. Global Asthma Reliever (Rescue) Medications Revenue by Type (2017-2022) & ($ million)

Table 8. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2017-2022)

Table 9. Global Asthma Reliever (Rescue) Medications Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Asthma Reliever (Rescue) Medications Sales by Application (2017-2022) & (K Units)

Table 11. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2022)

Table 12. Global Asthma Reliever (Rescue) Medications Revenue by Application (2017-2022)

Table 13. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2017-2022)

Table 14. Global Asthma Reliever (Rescue) Medications Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Asthma Reliever (Rescue) Medications Sales by Company (2020-2022) & (K Units)

Table 16. Global Asthma Reliever (Rescue) Medications Sales Market Share by Company (2020-2022)

Table 17. Global Asthma Reliever (Rescue) Medications Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Company (2020-2022)

Table 19. Global Asthma Reliever (Rescue) Medications Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Asthma Reliever (Rescue) Medications Producing Area Distribution and Sales Area

Table 21. Players Asthma Reliever (Rescue) Medications Products Offered

Table 22. Asthma Reliever (Rescue) Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Asthma Reliever (Rescue) Medications Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Asthma Reliever (Rescue) Medications Sales Market Share Geographic Region (2017-2022)

Table 27. Global Asthma Reliever (Rescue) Medications Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Asthma Reliever (Rescue) Medications Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Asthma Reliever (Rescue) Medications Sales Market Share by Country/Region (2017-2022)

Table 31. Global Asthma Reliever (Rescue) Medications Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Asthma Reliever (Rescue) Medications Sales by Country (2017-2022) & (K Units)

Table 34. Americas Asthma Reliever (Rescue) Medications Sales Market Share by Country (2017-2022)

Table 35. Americas Asthma Reliever (Rescue) Medications Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Asthma Reliever (Rescue) Medications Revenue Market Share by Country (2017-2022)

Table 37. Americas Asthma Reliever (Rescue) Medications Sales by Type (2017-2022) & (K Units)

Table 38. Americas Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2022)

Table 39. Americas Asthma Reliever (Rescue) Medications Sales by Application (2017-2022) & (K Units)

Table 40. Americas Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2022)

Table 41. APAC Asthma Reliever (Rescue) Medications Sales by Region (2017-2022) & (K Units)

Table 42. APAC Asthma Reliever (Rescue) Medications Sales Market Share by Region (2017-2022)

Table 43. APAC Asthma Reliever (Rescue) Medications Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2017-2022)

Table 45. APAC Asthma Reliever (Rescue) Medications Sales by Type (2017-2022) & (K Units)

Table 46. APAC Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2022)

Table 47. APAC Asthma Reliever (Rescue) Medications Sales by Application (2017-2022) & (K Units)

Table 48. APAC Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2022)

Table 49. Europe Asthma Reliever (Rescue) Medications Sales by Country (2017-2022) & (K Units)

Table 50. Europe Asthma Reliever (Rescue) Medications Sales Market Share by Country (2017-2022)

Table 51. Europe Asthma Reliever (Rescue) Medications Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Asthma Reliever (Rescue) Medications Revenue Market Share by Country (2017-2022)

Table 53. Europe Asthma Reliever (Rescue) Medications Sales by Type (2017-2022) & (K Units)

Table 54. Europe Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2022)

Table 55. Europe Asthma Reliever (Rescue) Medications Sales by Application (2017-2022) & (K Units)

Table 56. Europe Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Asthma Reliever (Rescue) Medications Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Asthma Reliever (Rescue) Medications Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Asthma Reliever (Rescue) Medications Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Asthma Reliever (Rescue) Medications Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Asthma Reliever (Rescue) Medications Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Asthma Reliever (Rescue) Medications Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Asthma Reliever (Rescue) Medications

Table 66. Key Market Challenges & Risks of Asthma Reliever (Rescue) Medications

Table 67. Key Industry Trends of Asthma Reliever (Rescue) Medications

Table 68. Asthma Reliever (Rescue) Medications Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Asthma Reliever (Rescue) Medications Distributors List

Table 71. Asthma Reliever (Rescue) Medications Customer List

Table 72. Global Asthma Reliever (Rescue) Medications Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Asthma Reliever (Rescue) Medications Sales Market Forecast by Region

Table 74. Global Asthma Reliever (Rescue) Medications Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Asthma Reliever (Rescue) Medications Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Asthma Reliever (Rescue) Medications Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Asthma Reliever (Rescue) Medications Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Asthma Reliever (Rescue) Medications Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Asthma Reliever (Rescue) Medications Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Asthma Reliever (Rescue) Medications Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Asthma Reliever (Rescue) Medications Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Asthma Reliever (Rescue) Medications Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Asthma Reliever (Rescue) Medications Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Asthma Reliever (Rescue) Medications Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Asthma Reliever (Rescue) Medications Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Asthma Reliever (Rescue) Medications Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Asthma Reliever (Rescue) Medications Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Asthma Reliever (Rescue) Medications Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Asthma Reliever (Rescue) Medications Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Asthma Reliever (Rescue) Medications Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Asthma Reliever (Rescue) Medications Revenue Market Share Forecast by Application (2023-2028)

Table 92. Dulera Basic Information, Asthma Reliever (Rescue) Medications Manufacturing Base, Sales Area and Its Competitors

Table 93. Dulera Asthma Reliever (Rescue) Medications Product Offered

Table 94. Dulera Asthma Reliever (Rescue) Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Dulera Main Business

Table 96. Dulera Latest Developments

Table 97. QVAR Basic Information, Asthma Reliever (Rescue) Medications Manufacturing Base, Sales Area and Its Competitors

Table 98. QVAR Asthma Reliever (Rescue) Medications Product Offered

Table 99. QVAR Asthma Reliever (Rescue) Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. QVAR Main Business

Table 101. QVAR Latest Developments

Table 102. Glaxosmithkline plc Basic Information, Asthma Reliever (Rescue) Medications Manufacturing Base, Sales Area and Its Competitors

Table 103. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Offered

Table 104. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Glaxosmithkline plc Main Business

Table 106. Glaxosmithkline plc Latest Developments

Table 107. MAP Pharmaceuticals,Inc Basic Information, Asthma Reliever (Rescue) Medications Manufacturing Base, Sales Area and Its Competitors

Table 108. MAP Pharmaceuticals,Inc Asthma Reliever (Rescue) Medications Product Offered

Table 109. MAP Pharmaceuticals,Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. MAP Pharmaceuticals,Inc Main Business

Table 111. MAP Pharmaceuticals,Inc Latest Developments

Table 112. Merck & Co. Inc Basic Information, Asthma Reliever (Rescue) Medications Manufacturing Base, Sales Area and Its Competitors

Table 113. Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Offered

Table 114. Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Merck & Co. Inc Main Business

Table 116. Merck & Co. Inc Latest Developments

Table 117. AstraZeneca plc Basic Information, Asthma Reliever (Rescue) Medications Manufacturing Base, Sales Area and Its Competitors

Table 118. AstraZeneca plc Asthma Reliever (Rescue) Medications Product Offered

Table 119. AstraZeneca plc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. AstraZeneca plc Main Business

Table 121. AstraZeneca plc Latest Developments

Table 122. Roche Holdings Ltd Basic Information, Asthma Reliever (Rescue) Medications Manufacturing Base, Sales Area and Its Competitors

Table 123. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Offered

Table 124. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Roche Holdings Ltd Main Business

Table 126. Roche Holdings Ltd Latest Developments

Table 127. Genentech Inc Basic Information, Asthma Reliever (Rescue) Medications Manufacturing Base, Sales Area and Its Competitors

Table 128. Genentech Inc Asthma Reliever (Rescue) Medications Product Offered

Table 129. Genentech Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Genentech Inc Main Business

Table 131. Genentech Inc Latest Developments

Table 132. Sepracor, Inc Basic Information, Asthma Reliever (Rescue) Medications Manufacturing Base, Sales Area and Its Competitors

Table 133. Sepracor, Inc Asthma Reliever (Rescue) Medications Product Offered

Table 134. Sepracor, Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Sepracor, Inc Main Business

Table 136. Sepracor, Inc Latest Developments

Table 137. Schering-Plough Corp Basic Information, Asthma Reliever (Rescue) Medications Manufacturing Base, Sales Area and Its Competitors

Table 138. Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Offered

Table 139. Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Schering-Plough Corp Main Business

Table 141. Schering-Plough Corp Latest Developments

Table 142. Sanofi-Aventis Basic Information, Asthma Reliever (Rescue) Medications Manufacturing Base, Sales Area and Its Competitors

Table 143. Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Offered

Table 144. Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Sanofi-Aventis Main Business

Table 146. Sanofi-Aventis Latest Developments

Table 147. Theravance Inc Basic Information, Asthma Reliever (Rescue) Medications Manufacturing Base, Sales Area and Its Competitors

Table 148. Theravance Inc Asthma Reliever (Rescue) Medications Product Offered

Table 149. Theravance Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Theravance Inc Main Business

Table 151. Theravance Inc Latest Developments

List of Figures

Figure 1. Picture of Asthma Reliever (Rescue) Medications

Figure 2. Asthma Reliever (Rescue) Medications Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Asthma Reliever (Rescue) Medications Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Asthma Reliever (Rescue) Medications Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Asthma Reliever (Rescue) Medications Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Quick-Relief Medications

Figure 10. Product Picture of Long-Term Control Medications

Figure 11. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type in 2021

Figure 12. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2017-2022)

Figure 13. Asthma Reliever (Rescue) Medications Consumed in Children

Figure 14. Global Asthma Reliever (Rescue) Medications Market: Children (2017-2022) & (K Units)

Figure 15. Asthma Reliever (Rescue) Medications Consumed in Adolescent

Figure 16. Global Asthma Reliever (Rescue) Medications Market: Adolescent (2017-2022) & (K Units)

Figure 17. Asthma Reliever (Rescue) Medications Consumed in Adult

Figure 18. Global Asthma Reliever (Rescue) Medications Market: Adult (2017-2022) & (K Units)

Figure 19. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2022)

Figure 20. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application in 2021

Figure 21. Asthma Reliever (Rescue) Medications Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Company in 2021

Figure 23. Global Asthma Reliever (Rescue) Medications Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Geographic Region in 2021

Figure 25. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2017-2022)

Figure 26. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Country/Region in 2021

Figure 27. Americas Asthma Reliever (Rescue) Medications Sales 2017-2022 (K Units)

Figure 28. Americas Asthma Reliever (Rescue) Medications Revenue 2017-2022 ($ Millions)

Figure 29. APAC Asthma Reliever (Rescue) Medications Sales 2017-2022 (K Units)

Figure 30. APAC Asthma Reliever (Rescue) Medications Revenue 2017-2022 ($ Millions)

Figure 31. Europe Asthma Reliever (Rescue) Medications Sales 2017-2022 (K Units)

Figure 32. Europe Asthma Reliever (Rescue) Medications Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Asthma Reliever (Rescue) Medications Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Asthma Reliever (Rescue) Medications Revenue 2017-2022 ($ Millions)

Figure 35. Americas Asthma Reliever (Rescue) Medications Sales Market Share by Country in 2021

Figure 36. Americas Asthma Reliever (Rescue) Medications Revenue Market Share by Country in 2021

Figure 37. United States Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Asthma Reliever (Rescue) Medications Sales Market Share by Region in 2021

Figure 42. APAC Asthma Reliever (Rescue) Medications Revenue Market Share by Regions in 2021

Figure 43. China Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Asthma Reliever (Rescue) Medications Sales Market Share by Country in 2021

Figure 50. Europe Asthma Reliever (Rescue) Medications Revenue Market Share by Country in 2021

Figure 51. Germany Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Asthma Reliever (Rescue) Medications Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Asthma Reliever (Rescue) Medications Revenue Market Share by Country in 2021

Figure 58. Egypt Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Asthma Reliever (Rescue) Medications Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Asthma Reliever (Rescue) Medications in 2021

Figure 64. Manufacturing Process Analysis of Asthma Reliever (Rescue) Medications

Figure 65. Industry Chain Structure of Asthma Reliever (Rescue) Medications

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390